Aptevo Therapeutics Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Aptevo Therapeutics Inc. (APVO) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$157.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-03-26
- Aptevo Therapeutics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $434.00K, a 33.95% increase year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $724.00K, a 56.03% increase year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-06-30 was -$501.00K.
- Aptevo Therapeutics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-03-31 was -$814.00K.
- Aptevo Therapeutics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$157.00K.
- Aptevo Therapeutics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$1.02M, a 296.33% decline from fiscal 2023.
- Aptevo Therapeutics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $518.00K.
- Aptevo Therapeutics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$394.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $434.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.16M derived: sum of 2 quarters · filed 2026-03-26 | $657.00K derived: sum of 3 quarters · filed 2026-03-26 | -$157.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $724.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $223.00K derived: sum of 2 quarters · filed 2025-11-06 | -$591.00K 10-Q · filed 2025-11-06 | -$267.00K derived: sum of 4 quarters · filed 2026-03-26 | |
| 2025-06-30 | -$501.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$1.31M 10-Q · filed 2025-08-11 | -$991.00K derived: sum of 3 quarters · filed 2026-03-26 | -$527.00K derived: sum of 4 quarters · filed 2026-03-26 | |
| 2025-03-31 | -$814.00K 10-Q · filed 2025-05-15 | -$490.00K derived: sum of 2 quarters · filed 2026-03-26 | -$26.00K derived: sum of 3 quarters · filed 2026-03-26 | -$905.00K derived: sum of 4 quarters · filed 2026-03-26 | |
| 2024-12-31 | $324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $788.00K derived: sum of 2 quarters · filed 2026-03-26 | -$91.00K derived: sum of 3 quarters · filed 2026-03-26 | -$1.02M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $464.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$415.00K derived: sum of 2 quarters · filed 2025-11-06 | -$1.34M 10-Q · filed 2025-11-06 | -$952.00K derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$879.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$1.80M 10-Q · filed 2025-08-11 | -$1.42M derived: sum of 3 quarters · filed 2025-08-11 | -$1.49M derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | -$926.00K 10-Q · filed 2025-05-15 | -$537.00K derived: sum of 2 quarters · filed 2025-05-15 | -$613.00K derived: sum of 3 quarters · filed 2025-05-15 | $501.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $313.00K derived: sum of 2 quarters · filed 2025-02-14 | $1.43M derived: sum of 3 quarters · filed 2025-02-14 | $518.00K 10-K · filed 2025-02-14 | |
| 2023-09-30 | -$76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.04M derived: sum of 2 quarters · filed 2024-11-07 | $129.00K 10-Q · filed 2024-11-07 | $1.12M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $205.00K 10-Q · filed 2024-08-08 | $1.19M derived: sum of 3 quarters · filed 2024-08-08 | $2.06M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$909.00K 10-Q · filed 2024-05-08 | $80.00K derived: sum of 2 quarters · filed 2024-05-08 | $942.00K derived: sum of 3 quarters · filed 2024-05-08 | -$505.00K derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $989.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.85M derived: sum of 2 quarters · filed 2024-03-05 | $404.00K derived: sum of 3 quarters · filed 2024-03-05 | -$394.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | $862.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$585.00K derived: sum of 2 quarters · filed 2023-11-14 | -$1.38M 10-Q · filed 2023-11-14 | -$1.60M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$2.25M 10-Q · filed 2023-08-10 | -$2.46M derived: sum of 3 quarters · filed 2023-08-10 | -$2.01M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$798.00K 10-Q · filed 2023-05-11 | -$1.02M derived: sum of 2 quarters · filed 2023-05-11 | -$561.00K derived: sum of 3 quarters · filed 2023-05-11 | -$603.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $237.00K derived: sum of 2 quarters · filed 2023-03-30 | $195.00K derived: sum of 3 quarters · filed 2023-03-30 | -$1.92M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $415.00K derived: sum of 2 quarters · filed 2022-11-10 | -$1.70M 10-Q · filed 2022-11-10 | $427.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$2.15M 10-Q · filed 2022-08-11 | -$30.00K derived: sum of 3 quarters · filed 2022-08-11 | $385.00K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$2.11M 10-Q · filed 2022-05-12 | $12.00K derived: sum of 2 quarters · filed 2022-05-12 | $427.00K derived: sum of 3 quarters · filed 2022-05-12 | $436.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $2.54M derived: sum of 2 quarters · filed 2022-03-24 | $2.55M derived: sum of 3 quarters · filed 2022-03-24 | -$702.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $415.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $424.00K derived: sum of 2 quarters · filed 2021-11-12 | -$2.82M 10-Q · filed 2021-11-12 | -$5.36M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$3.24M 10-Q · filed 2021-08-12 | -$5.77M derived: sum of 3 quarters · filed 2021-08-12 | -$4.69M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$3.25M 10-Q · filed 2021-05-11 | -$5.78M derived: sum of 2 quarters · filed 2021-05-11 | -$4.70M derived: sum of 3 quarters · filed 2021-05-11 | -$6.31M derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$1.45M derived: sum of 2 quarters · filed 2021-03-31 | -$3.06M derived: sum of 3 quarters · filed 2021-03-31 | -$2.70M 10-K · filed 2021-03-31 | $938.00K 10-K · filed 2020-03-25 |
| 2019-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$530.00K derived: sum of 2 quarters · filed 2020-11-10 | -$162.00K 10-Q · filed 2020-11-10 | $1.55M derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$1.25M 10-Q · filed 2020-08-14 | $465.00K derived: sum of 3 quarters · filed 2020-08-14 | $1.87M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $368.00K 10-Q · filed 2020-05-13 | $2.08M derived: sum of 2 quarters · filed 2020-05-13 | $3.49M derived: sum of 3 quarters · filed 2020-05-13 | $5.02M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $3.12M derived: sum of 2 quarters · filed 2020-03-25 | $4.65M derived: sum of 3 quarters · filed 2020-03-25 | $1.28M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.94M derived: sum of 2 quarters · filed 2019-11-07 | -$432.00K 10-Q · filed 2019-11-07 | $1.70M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$1.84M 10-Q · filed 2019-08-09 | $296.00K derived: sum of 3 quarters · filed 2019-08-09 | ||
| 2018-03-31 | -$3.37M 10-Q · filed 2019-05-09 | -$1.24M derived: sum of 2 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $195.00K 10-K · filed 2019-03-18 | |||
| 2017-09-30 | -$1.94M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |